- Query in any language with multilingual search
- Access EUR-Lex and EU Commission case law
- See relevant paragraphs highlighted instantly
Similar Documents
Explore similar documents to your case.We Found Similar Cases for You
Case T-181/23: Judgment of the General Court of 15 May 2024 – Dermavita Company v EUIPO – Allergan Holdings France (JUVÉDERM) (EU trade mark – Invalidity proceedings – EU word mark JUVÉDERM – Absolute ground for invalidity – No bad faith – Article 51(1)(b) of Regulation (EC) No 40/94 (now Article 59(1)(b) of Regulation (EU) 2017/1001))
ECLI:EU:UNKNOWN:62023TA0181
62023TA0181
With us you find everything. Try it now!
I imagine what I want to write in my case, I write it in the search engine and I get exactly what I wanted. Thank you!
Valentina R., lawyer
Official Journal of the European Union
C series
—
C/2024/3914
(Case T-181/23)
(EU trade mark - Invalidity proceedings - EU word mark JUVÉDERM - Absolute ground for invalidity - No bad faith - Article 51(1)(b) of Regulation (EC) No 40/94 (now Article 59(1)(b) of Regulation (EU) 2017/1001))
(C/2024/3914)
Language of the case: English
Parties
Applicant: Dermavita Company S.a.r.l. (Beirut, Lebanon) (represented by: D. Todorov, lawyer)
Defendant: European Union Intellectual Property Office (represented by: E. Markakis, acting as Agent)
Other party to the proceedings before the Board of Appeal of EUIPO, intervener before the General Court: Allergan Holdings France (Courbevoie, France) (represented by: T. de Haan and S. Vandezande, lawyers, and by J. Day, Solicitor)
Re:
By its action under Article 263 TFEU, the applicant seeks the annulment of the decision of the Fourth Board of Appeal of the European Union Intellectual Property Office (EUIPO) of 1 February 2023 (Case R 904/2022-4).
Operative part of the judgment
The Court:
1.Dismisses the action;
2.Orders Dermavita Company S.a.r.l. to pay the costs.
—
Language of the case: English.
OJ C 179, 22.5.2023.
ELI: http://data.europa.eu/eli/C/2024/3914/oj
ISSN 1977-091X (electronic edition)
—
* * *